Antonio Riccardo Buonomo
Biographic Data
| ID | 7885602 |
|---|---|
| NAME | Antonio Riccardo Buonomo |
| GIVEN NAMES | Antonio Riccardo |
| FAMILY NAME | Buonomo |
| SIGNATURE | BUONOMO A R |
| AFFILIATIONS | University of Naples Federico II |
| ORCID | 0000-0002-4378-8366 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Covid-19 Post-Exposure Evaluation (Cope) Study
Campania is the sixth poorest region of Italy, and it is the region with the highest income inequality. The secondary attack rates of SARS-CoV-2 among households are found to be substantially heterogeneous among published studies and are influenced by socio-economic factors. We conducted a retrospective study to describe the role of socio-economic factors in the household transmission of SARS-CoV-2 among patients living in Campania Region and ref…
Monoclonal Antibodies against Sars-CoV-2
Even several months after the start of a massive vaccination campaign against COVID-19, mortality and hospital admission are still high in many countries. Monoclonal antibodies against SARS-CoV-2 are the ideal complement to vaccination in infected subjects who are at high risk for progression to severe disease. Based on data of the Italian Ministry of Health, in the period April-August 2021, monoclonal antibodies were prescribed to 6322 patients.…
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from Covid-19
The use of corticosteroids for COVID-19 respiratory impairment seems to be the most common risk factor for PJP, together with viral-induced and iatrogenic lymphopenia. The worsening in respiratory function and the characteristic radiological picture during or after COVID-19 pneumonia should raise the suspicion of PJP, even in immunocompetent patients. PJP primary chemoprophylaxis can be considered in selected high-risk COVID-19 patients, but furt…
No prominent works on this page.
Monoclonal Antibodies against Sars-CoV-2
Even several months after the start of a massive vaccination campaign against COVID-19, mortality and hospital admission are still high in many countries. Monoclonal antibodies against SARS-CoV-2 are the ideal complement to vaccination in infected subjects who are at high risk for progression to severe disease. Based on data of the Italian Ministry of Health, in the period April-August 2021, monoclonal antibodies were prescribed to 6322 patients.…
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from Covid-19
The use of corticosteroids for COVID-19 respiratory impairment seems to be the most common risk factor for PJP, together with viral-induced and iatrogenic lymphopenia. The worsening in respiratory function and the characteristic radiological picture during or after COVID-19 pneumonia should raise the suspicion of PJP, even in immunocompetent patients. PJP primary chemoprophylaxis can be considered in selected high-risk COVID-19 patients, but furt…
Covid-19 Post-Exposure Evaluation (Cope) Study
Campania is the sixth poorest region of Italy, and it is the region with the highest income inequality. The secondary attack rates of SARS-CoV-2 among households are found to be substantially heterogeneous among published studies and are influenced by socio-economic factors. We conducted a retrospective study to describe the role of socio-economic factors in the household transmission of SARS-CoV-2 among patients living in Campania Region and ref…
Coronavirus disease 2019 (COVID-19 (3 works) · Disease (3 works) · Medicine (3 works) · COVID-19 epidemiological studies (2 works) · Internal Medicine (2 works) · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 (2 works) · 2019-20 coronavirus outbreak (1 work) · Antibody (1 work) · Chemoprophylaxis (1 work) · Christian ministry (1 work)